Power Law company profile

Ovid Therapeutics

Biotech & Life Sciences · New York City, United States · Founded 2014 · IPO 2017 Thoroughbred

A biopharmaceutical company focused exclusively on developing impactful medicines for patients and families living with rare neurological disorders

Valuation

$423M

Market cap · May/2026

Revenue

$7.3M

Latest reported FY

Featured in $10B+ revenueThoroughbred · Power Law outcome

Investors

11 investors on Ovid Therapeutics's cap table

Sourced from Dealroom's funding history. Investor profile links are shown where available.

Series B+ 11 investors entered at this stage

Point72

Coastlands Capital

Affinity Asset Advisors

Ally Bridge Group

Eventide Asset Management

ADAR1 Capital Management

Adage Capital

Balyasny Asset Management

Janus Henderson Investors

RA Capital Management

Fidelity Investments

Global footprint

Where Ovid Therapeutics has talent and traffic

AI talent share

2.5% of workforce is AI talent
(1 of 40 staff)

Core AI12.5%

Other AI00%

Non-AI workforce3997.5%

Workforce by country

1 countries with
team presence

🇺🇸 United States100%

1 country shown

Web traffic by country

7.2K monthly visits
across markets

🇺🇸 United States80.6%

🇮🇳 India18.1%

🇬🇧 United Kingdom1.4%

Top 3 markets shown

Market sentiment

What the market is saying about Ovid Therapeutics

An AI-synthesized read of the highest-engagement posts about Ovid Therapeutics on X over the past 7 days. We rank by likes & retweets, ignore corporate channels, and surface the themes that broke out from real people.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Ovid Therapeutics on the full Dealroom platform

Live deal flow, founder pedigree, hiring signals, revenue trajectory, and the full cap table.

Book a demo Explore company profiles